User testing in developing patient medication information in Europe

Research in Social and Administrative Pharmacy

Volumn 9, Issue 5, 2013, Pages 640-645

  Raynor, D K ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM DERIVATIVE; TRANQUILIZER;

BIPOLAR DISORDER; DRUG LABELING; EUROPE; FEMALE; HEALTH LITERACY; HUMAN; MALE; NOTE; PATIENT EDUCATION; PUBLICATION; QUESTIONNAIRE;

ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG LABELING; EUROPE; FEMALE; HEALTH LITERACY; HUMANS; LITHIUM COMPOUNDS; MALE; PAMPHLETS; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES;

EID: 84884412411     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.02.007     Document Type: Note

References (20)

1. Raynor D.K. Medication literacy is a 2-way street. Mayo Clin Proc 2008, 83:520-522.
2. Rudd R.E. Improving American's health literacy. NEngl J Med 2010, 363:2283-2284.
3. Agency for Healthcare Research and Quality. Health literacy universal precautions toolkit, Available at, Accessed 26.07.12. http://www.ahrq.gov/qual/literacy/index.html.
4. Brach C., Dreyer B., Schyve P., et al. Attributes ofa healthliterate organization Available at, Accessed 26.07.12. http://www.iom.edu/%7E/media/Files/Perspectives-Files/2012/Discussion-Papers/BPH_HLit_Attributes.pdf.
5. Council Directive. The Labelling of Medicinal Products for Human Use and on Package Leaflets 1992, European Commission, European Commission, Brussels.
6. Guideline on the readability of the labelling and package leaflet of medicinal products for human use European Commission, Available at, Accessed 26.07.12. http://ec.europa.eu/health/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf.
7. Always Read the Leaflet: Getting the Best Information with Every Medicine. Report of the Committee on Safety of Medicines Working Group on Patient Information 2005, Medicines and Healthcare Products Regulatory Agency, The Stationery Office, London.
8. Raynor D.K., Knapp P., Silcock J., Parkinson B., Feeney K. "User testing" as a method for testing the fitness-for-purpose of written medicine information. Patient Educ Counsel 2011, 83:404-410.
9. Sless D., Shrensky R. Writing About Medicines for People 2006, Australian Self-Medication Industry, Sydney. 3rd ed.
10. Raynor D.K., Dickinson D. Key principles to guide development of consumer medicines information. Ann Pharmacother 2009, 43:700-706.
11. Sless D. PIL testing: misapplied and out of context. Regulatory Rapporteur 2007, 14.
12. Jay E., Aslani P., Raynor D.K. User testing of consumer medicines information in Australia. Health Educ J 2010, 70:420-427.
13. Harris E., Enright D. New words for cautionary and advisory labels make them easily understood. Pharmaceut J 2011, 286:278-279.
14. Knapp P., Gardner P., Raynor D. Are instructions for use (IFUs) provided with medical devices supplied in community pharmacies fit for purpose?. Int J Pharm Pract 2009, 17:B88-B89.
15. Knapp P., Raynor D.K., Silcock J., Parkinson B. Can user testing of a clinical trial patient information sheet make it fit-for-purpose?-A randomized controlled trial. BMC Med 2011, 9:89.
16. Knapp P., Raynor D.K., Waxman R., Wanklyn P. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract 2010, 18:362-369.
17. Gerrett D., Lamont T., Paton C., Barnes T.R.E., Shah A. Prescribing and monitoring lithium therapy: summary of a safety report from the NPSA. BMJ 2010, 341:c6258.
18. Safer lithium therapy (Patient safety alert PSA005) National Patient Safety Agency, Available at, Accessed 26.07.12. http://www.nrls.npsa.nhs.uk/resources/type/alerts/%3fentryid45%3d65426.
19. Available at: Accessed 26.07.12. http://www.brookings.edu/about/centers/health/projects/pmi.
20. Raynor D.K., Blenkinsopp A., Knapp P., et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess 2007, 11:1-160.